Ahlstrom-Munksjö enhances its high protection medical fabric portfolio with the addition of TrustShield™ Biological

Ahlstrom-Munksjö announces the launch of TrustShield™ Biological, a personal protective apparel medical fabric designed to shield against hazardous pathogens.

The TrustShield™ product portfolio offers a range of medical fabrics designed to provide superior protection in the operating room, clinical and laboratory environments. TrustShield™ fabrics are laser resistant, protect against chemical permeation, and are highly absorbent. They can be easily converted into medical grade gowns or drapes.

TrustShield™ Biological is designed for personal protective apparel applications requiring biological protection to prevent penetration of blood and other hazardous fluids that can spread and cause infections. TrustShield™ Biological is a bi-laminate (two layer) fabric that consists of a polypropylene based nonwoven layer designed for comfort, and polyethylene film layer for protection against biohazards.

“It is important to focus on how we can advance product functionality in our smart fiber-based solutions. This holds true especially for our medical business and the protective fabrics we produce to keep front line workers safe. TrustShield™ Biological further underscores our mission to deliver high performing medical fabrics that fully protect health care workers and patients globally,” commented Lionel Bonte, Vice President, Medical, Ahlstrom-Munksjö.

For decades the medical business has been making fabrics used to construct surgical gowns, drapes, pleated face masks, protective apparel and sterile barrier systems. These high performing medical fabrics are used around the world to protect health care workers and patients against viruses, bacteria and fluids. TrustShield™ Biological joins Ahlstrom-Munksjö’s high protection portfolio, which includes ViroSēl™ and PureArmor®, Ahlstrom-Munksjö’s next generation breathable viral barrier (BVB) fabrics. These innovative fabrics offer both protection and comfort, something that is difficult to achieve together.
https://www.ahlstrom-munksjo.com/Media/releases/press-releases2/2020/ahlstrom-munksjo-enhances-its-high-protection-medical-fabric-portfolio-with-the-addition-of-trustshield-biological/

Related Posts

NORPAC Announces Price Increase on Orca Offset

Effective with shipments on or after October 1, 2017, NORPAC will increase the price of our uncoated freesheet papers by $2.00/cwt. This includes all mill-branded as well as private and generic labeled cut-size and rolls. All up-charges and shipping policies remain unchanged.

RYAM Announces Second Quarter 2022 Results

Rayonier Advanced Materials Inc. reported a net loss of $23 million or $(0.36) per diluted share for the quarter ended June 25, 2022, compared to net income of $122 million or $1.89 per diluted share for the same prior year quarter. The net loss from continuing operations for the quarter ended June 25, 2022, was $25 million or $(0.39) per diluted share, compared to net income from continuing operations of $8 million or $0.13 per diluted share for the same prior year quarter. Net income from continuing operations in the prior year quarter included a $25 million tax benefit resulting from remeasuring the Company’s Canadian deferred tax assets at a higher tax rate following the announcement of the disposal. Unless otherwise stated, information in this press release relates to continuing operations.

Mercer International Inc. Reports Strong 2017 Third Quarter Results

Mercer International Inc. reported strong results for the third quarter ended September 30, 2017 as Operating EBITDA* increased by 34% to $64.0 million from $47.9 million in the same quarter of 2016 and by 64% from $39.1 million in the prior quarter. In the current quarter, net income increased to $21.1 million, or $0.33 per basic and $0.32 per diluted share, compared to net income of $11.9 million, or $0.18 per basic and diluted share, in the comparative quarter and a net loss of $2.1 million in the prior quarter. Mr. David M. Gandossi, the Chief Executive Officer, stated: "In the third quarter of 2017, pulp prices in Europe and North America increased as a result of continued steady demand and were generally flat in China compared to the prior quarter of 2017. Overall our average pulp sales realizations were approximately 2% higher in the third quarter of 2017 compared to the prior quarter of 2017. " Click Read More below for additional information.
Back To Top
×Close search
Search